Literature DB >> 22460119

Neurodegenerative disease: RXR agonist reverses Alzheimer's disease.

Sarah Crunkhorn.   

Abstract

Entities:  

Year:  2012        PMID： 22460119     DOI： 10.1038/nrd3706

Source DB:  PubMed          Journal:  Nat Rev Drug Discov        ISSN： 1474-1776            Impact factor:   84.694


× No keyword cloud information.
  1 in total

1.  ApoE-directed therapeutics rapidly clear β-amyloid and reverse deficits in AD mouse models.

Authors:  Paige E Cramer; John R Cirrito; Daniel W Wesson; C Y Daniel Lee; J Colleen Karlo; Adriana E Zinn; Brad T Casali; Jessica L Restivo; Whitney D Goebel; Michael J James; Kurt R Brunden; Donald A Wilson; Gary E Landreth
Journal:  Science       Date:  2012-02-09       Impact factor: 47.728
  1 in total
  4 in total

Review 1.  Emerging roles for nuclear receptors in the pathogenesis of age-related macular degeneration.

Authors:  Goldis Malek; Eleonora M Lad
Journal:  Cell Mol Life Sci       Date:  2014-08-26       Impact factor: 9.261

Review 2.  Brain metabolite clearance: impact on Alzheimer's disease.

Authors:  Juan M Zolezzi; Nibaldo C Inestrosa
Journal:  Metab Brain Dis       Date:  2014-03-25       Impact factor: 3.584

Review 3.  Retinoid X Receptor: Cellular and Biochemical Roles of Nuclear Receptor with a Focus on Neuropathological Involvement.

Authors:  Samridhi Sharma; Ting Shen; Nitin Chitranshi; Veer Gupta; Devaraj Basavarajappa; Soumalya Sarkar; Mehdi Mirzaei; Yuyi You; Wojciech Krezel; Stuart L Graham; Vivek Gupta
Journal:  Mol Neurobiol       Date:  2022-01-11       Impact factor: 5.682

4.  Potential retinoid x receptor agonists for treating Alzheimer's disease from traditional chinese medicine.

Authors:  Kuan-Chung Chen; Yu-Cheng Liu; Cheng-Chun Lee; Calvin Yu-Chian Chen
Journal:  Evid Based Complement Alternat Med       Date:  2014-04-30       Impact factor: 2.629
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.